Tempus AI (NASDAQ:TEM) Shares Gap Down - Here's What Happened

Key Points

• Tempus AI shares opened at $93.36, down from a previous close of $96.39, with a trading volume of 3,086,762 shares.
• Analysts have varied ratings on Tempus AI, with a consensus rating of "Hold" and a target price of $71.83.
• The company reported quarterly earnings of ($0.22) EPS, surpassing estimates, and a year-over-year revenue increase of 89.5% to $314.64 million.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $96.39, but opened at $93.36. Tempus AI shares last traded at $96.00, with a volume of 3,086,762 shares.

Analyst Upgrades and Downgrades

TEM has been the subject of a number of analyst reports. Morgan Stanley raised their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Bank of America lifted their target price on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Friday, August 8th. HC Wainwright boosted their price objective on Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a report on Friday, September 12th. Finally, Piper Sandler restated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of "Hold" and a consensus target price of $71.83.

Tempus AI Stock Performance

The company has a market cap of $16.37 billion, a PE ratio of -79.06 and a beta of 4.87. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The company has a 50-day moving average of $78.89 and a 200-day moving average of $64.87.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. During the same quarter in the previous year, the firm earned ($6.86) earnings per share. Tempus AI's quarterly revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. As a group, analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insiders Place Their Bets

In other Tempus AI news, CFO James William Rogers sold 7,528 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer owned 138,473 shares of the company's stock, valued at approximately $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Ryan Fukushima sold 17,460 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the transaction, the chief operating officer directly owned 839,180 shares in the company, valued at approximately $62,644,787. This represents a 2.04% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 933,662 shares of company stock valued at $68,070,993. 26.27% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Concord Wealth Partners lifted its position in shares of Tempus AI by 308.0% during the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after buying an additional 308 shares during the last quarter. GAMMA Investing LLC purchased a new position in shares of Tempus AI during the 3rd quarter valued at $28,000. Allworth Financial LP lifted its position in shares of Tempus AI by 5,000.0% during the 2nd quarter. Allworth Financial LP now owns 459 shares of the company's stock valued at $29,000 after buying an additional 450 shares during the last quarter. Cherry Tree Wealth Management LLC bought a new stake in shares of Tempus AI during the 1st quarter valued at $31,000. Finally, SouthState Corp raised its stake in shares of Tempus AI by 3,761.5% during the 2nd quarter. SouthState Corp now owns 502 shares of the company's stock valued at $32,000 after purchasing an additional 489 shares during the period. Hedge funds and other institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.